Niflec is one of 29 small molecule programs targeting Randomized. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
40 competitors in Randomized
Rayos
Tricor
Precedex
Methylthioninium Chloride
Yondelis
Zytiga
Rituxan
Erleada
Jaypirca
Clomid
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources